Payer PolicyActive
CG-LAB-28 Prostate Specific Antigen Testing
ANTHEM-CG-LAB-28
Anthem
Effective: April 16, 2025
Updated: December 30, 2025
Policy Summary
This policy addresses prostate-specific antigen (PSA) blood testing. PSA testing is medically necessary for prostate cancer screening; evaluation of signs or symptoms suggestive of prostate cancer; in individuals with previously elevated or rising PSA levels; or in those with a current or past history of prostate cancer, and is not medically necessary for any other indications.
Coverage Criteria Preview
Key requirements from the full policy
"Prostate specific antigen (PSA) testing is consideredmedically necessaryfor any of the following indications:"
Sign up to see full coverage criteria, indications, and limitations.